Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways

Malignant cancers employ diverse and intricate immune evasion strategies, which lead to inadequately effective responses of many clinical cancer therapies. However, emerging data suggest that activation of the tolerant innate immune system in cancer patients is able, at least partially, to counterac...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kai, Qu, Shuai, Chen, Xi, Wu, Qiong, Shi, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343938/
https://www.ncbi.nlm.nih.gov/pubmed/28216575
http://dx.doi.org/10.3390/ijms18020404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343938/
https://www.ncbi.nlm.nih.gov/pubmed/28216575
http://dx.doi.org/10.3390/ijms18020404

Ejemplares similares